MaxCyte Expects Q1 Sales To Beat Expectations, CFO Resigns
MaxCyte Inc (NASDAQ:MXCT) appointed Ron Holtz, current Senior Vice President, and Chief Accounting Officer, as the Interim Chief Financial Officer. The change comes as Amanda Murphy has resigned from her position as Chief Financial Officer, effective as of April 15, 2022, to pursue other interests. MaxCyte also expects Q1 FY22 sales of…
Benzinga ·